Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Genetic Testing in Irritable Bowel Syndrome

AI Summary
  • IBS is a complex polygenic disorder with substantial environmental modulation affecting phenotype and risk.
  • Despite numerous candidate gene and GWAS loci, the role of genetic testing for IBS in routine clinical practice remains uncertain.
  • Emergent areas such as pharmacogenetics and nutrigenetics may provide more immediate clinical applications guiding medication and dietary interventions.
Summarise with AI (MRCPsych/FRANZCP)

Gastroenterol Clin North Am. 2026 Dec;55(4):741-758. doi: 10.1016/j.gtc.2026.07.003. Epub 2026 Sep 9.

ABSTRACT

Irritable bowel syndrome (IBS) is a complex genetic disorder characterized by polygenic susceptibility with substantial environmental modulation. While many candidate gene studies and large genome-wide association studies have identified loci associated with IBS susceptibility, the role of genetic testing for IBS in clinical practice is uncertain. Instead, emergent areas such as pharmacogenetics and nutrigenetics may offer more immediate clinical applications by guiding medication or dietary interventions.

PMID:42933944 | DOI:10.1016/j.gtc.2026.07.003

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD